诱发性与无诱因静脉血栓栓塞症患者主要不良心血管事件发生率:RIETE登记研究
基于RIETE国际多中心登记2009–2017年数据,分析41,259例客观确诊VTE患者,其中55.6%为诱发性VTE。随访显示诱发性VTE患者发生MACE或MALE的风险高于无诱因VTE(HR 1.3,95%CI 1.1–1.5),调整传统心血管危险因素后诱发性VTE与MACE风险增加独立相关(HR 1.4,95%CI 1.1–1.7),癌症为MACE和MALE的显著预测因素。
要点
- 诱发性VTE患者主要动脉事件风险高于无诱因VTE。
- 癌症相关VTE患者MACE和MALE风险显著升高。
- 近期制动与动脉事件关联较强。
核心结论
- 在VTE患者中,诱发性病例尤其是癌症相关VTE患者主要动脉事件风险增加。
研究设计与样本
- 分析RIETE国际多中心登记2009–2017年连续录入的客观确诊VTE患者,限有动脉结局数据者,共41,259例,其中22,633例(55.6%)为诱发性VTE。
- 比较诱发性与无诱因VTE患者冠心病危险因素基线患病率,随访复合主要结局为MACE(卒中、心肌梗死、不稳定型心绞痛)和/或MALE。
- 采用χ2检验分析基线关联,Cox比例风险模型进行多因素分析,P<.05为统计学显著。
主要发现
- 随访期间诱发性VTE患者发生MACE或MALE的可能性高于无诱因VTE(HR 1.3;95%CI 1.1–1.5)。
- 近期制动(HR 1.4;95%CI 1.5–12.1)和癌症(HR 1.7;95%CI 1.4–1.9)与动脉事件关联较强。
- 调整多个传统心血管危险因素后,诱发性VTE相比无诱因VTE与MACE风险增加显著相关(HR 1.4;95%CI 1.1–1.7)。
- 在诱发性VTE患者中,癌症仍是MACE(HR 1.7;95%CI 1.4–2.1)和MALE(HR 2.1;95%CI 1.01–4.6)的显著独立预测因素。
临床怎么用
- 对诱发性VTE患者应关注主要动脉事件风险,尤其癌症相关VTE患者。
- 近期制动或癌症相关VTE患者可能需加强心血管风险监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Overlap exists between the risk factors for coronary artery disease and venous thromboembolism (VTE). However, a paucity of data is available on the incidence of major acute cardiovascular events (MACE) and major adverse limb events (MALE) among patients presenting with VTE. Moreover, it is unknown whether the rate of cardiovascular outcomes differs among patients with unprovoked vs provoked VTE. METHODS: We analyzed the data from 2009 to 2017 in the Registro Informatizado de Enfermedad Tromboembólica registry, an ongoing, multicenter, international registry of consecutive patients with a diagnosis of objectively confirmed VTE. The query was restricted it to patients with data entry for the arterial outcomes. The baseline prevalence of coronary artery disease risk factors was compared between patients with provoked (ie, immobility, cancer, surgery, travel >6 hours, hormonal causes) and unprovoked VTE. After the initial VTE event, we followed up patients for the composite primary outcome of incident MACE (ie, stroke, myocardial infarction, unstable angina) and/or MALE (ie, major limb events). We used the χ2 test for baseline associations and a Cox proportional hazard for multivariate analysis. We used IBM SPSS, version 24 (IBM Corp, Armonk, NY) for statistical analysis. A P value of <.05 was considered statistically significant. RESULTS: We analyzed the data from 41,259 patients with VTE, of whom 22,633 (55.6%) had experienced a provoked VTE. During follow-up, the patients with provoked VTE were more likely to develop MACE or MALE than were patients with unprovoked VTE (hazard ratio [HR], 1.3; 95% confidence interval [CI], 1.1-1.5). The association of arterial events with recent immobility (HR, 1.4; 95% CI, 1.5-12.1) and cancer (HR, 1.7; 95% CI, 1.4-1.9) was strong. After adjusting for multiple conventional cardiovascular risk factors, provoked VTE, compared with unprovoked VTE, was significantly associated with an increased hazard for MACE (HR, 1.4; 95% CI, 1.1-1.7). Cancer remained a significant adjusted predictor for both MACE (HR, 1.7; 95% CI, 1.4-2.1) and MALE (HR, 2.1; 95% CI 1.01-4.6) in those with provoked VTE. CONCLUSIONS: Among patients with VTE, provoked cases, specifically those with cancer-associated VTE, have an increased risk of major arterial events.
引用
- Golemi I, Cote L, Iftikhar O, et al. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31784355. doi:10.1016/j.jvsv.2019.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。